SCHEMBL3376524

SCHEMBL3376524

CC(C)(C)[Si](C)(C)Oc1cccc2c1ccn2C(=O)OCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.37
MAOA P21397 1/20 0.37
RCOR1 Q9UKL0 1/20 0.37
P2RX4 Q99571 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
P2RX1 P51575 1/20 0.37
P2RX3 P56373 1/20 0.37
ALDH1A1 P00352 2/20 0.36
SLC16A3 O15427 1/20 0.36
HTR2C P28335 1/20 0.36
TACR3 P29371 1/20 0.35
RECQL P46063 1/20 0.35
ROCK1 Q13464 1/20 0.35
PARP1 P09874 1/20 0.35
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29015481 0.83 HTR6 (0.46) KDM1AMAOARCOR1MEN1KMT2A
SCHEMBL29992652 0.82 AKT1 (0.40) MEN1KMT2A
SCHEMBL3044688 0.82 AKT1 (0.40) MEN1KMT2A
SCHEMBL13309267 0.78 NPC1 (0.48) KDM1AMAOARCOR1P2RX4MEN1
SCHEMBL3375069 0.76 TDP1 (0.47) KDM1AMAOARCOR1P2RX4MEN1
SCHEMBL3375727 0.76 KDM4E (0.43) KDM1AMAOARCOR1P2RX4MEN1
SCHEMBL3174940 0.75 PPARG (0.47) KMT2AALDH1A1
SCHEMBL4231904 0.74 TACR3 (0.46) KDM1AMAOARCOR1P2RX4MEN1
SCHEMBL4232805 0.73 TACR3 (0.43) KDM1AMAOARCOR1P2RX4MEN1
SCHEMBL4235703 0.73 P2RX4 (0.40) KDM1AMAOARCOR1P2RX4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1757585-B1 Anionically substituted 7-Nitroindoline derivatives and their uses MEDICAL RES COUNCIL (GB) 2010-12-01 EP disclosed
US-7737169-B2 Anionically substituted 7-nitroindoline derivatives and their uses MEDICAL RESEARCH COUNCIL (GB) 2010-06-15 US disclosed
US-20070203099-A1 Anionically substituted 7-nitroindoline derivatives and their uses UNITED KINGDOM RESEARCH AND INNOVATION (GB) 2007-08-30 US disclosed
EP-1757585-A1 Anionically substituted 7-Nitroindoline derivatives and their uses Medical Research Council (GB) 2007-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203099-A1 Anionically substituted 7-nitroindoline derivatives and their uses SLC18A3, SLC18A1, SLC18A2 KDM1A 3619/4885MAOA 107/4885RCOR1 4569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.